Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E- EPS (ttm)-0.01 Insider Own88.56% Shs Outstand494.49M Perf Week2.22%
Market Cap8.21B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float56.59M Perf Month21.35%
Enterprise Value8.20B PEG- EPS next Q- Inst Own0.13% Short Float2.09% Perf Quarter15.68%
Income-3.58M P/S- EPS this Y- Inst Trans-10.48% Short Ratio6.12 Perf Half Y6.00%
Sales0.00M P/B1688.71 EPS next Y- ROA-50.50% Short Interest1.18M Perf YTD12669.23%
Book/sh0.01 P/C1675.21 EPS next 5Y- ROE-54.81% 52W High83.60 -80.14% Perf Year11327.54%
Cash/sh0.01 P/FCF- EPS past 3/5Y22.39% -33.47% ROIC-70.39% 52W Low0.09 17789.96% Perf 3Y2678.85%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility6.69% 10.66% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM17.24% Oper. Margin- ATR (14)1.45 Perf 10Y-
Dividend Ex-Date- Quick Ratio7.39 Sales Y/Y TTM- Profit Margin- RSI (14)63.34 Recom-
Dividend Gr. 3/5Y- - Current Ratio7.39 EPS Q/Q22.22% SMA2020.67% Beta2.06 Target Price-
Payout- Debt/Eq0.11 Sales Q/Q- SMA509.40% Rel Volume0.88 Prev Close16.85
Employees10 LT Debt/Eq0.05 Earnings- SMA20034.03% Avg Volume193.58K Price16.60
IPOJul 16, 2021 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume169,778 Change-1.48%
Dec-11-25 08:24PM
Nov-24-25 09:05AM
Oct-22-25 05:47PM
Oct-01-25 01:39PM
Sep-04-25 01:01PM
03:51AM Loading…
Sep-03-25 03:51AM
Aug-04-25 03:51AM
Jul-31-25 11:31PM
Jul-17-25 03:51PM
Jul-08-25 02:26PM
Jul-07-25 10:34AM
Jul-01-25 03:51AM
Jun-30-25 04:03PM
Jun-27-25 12:05PM
05:18AM
03:06AM Loading…
Jun-20-25 03:06AM
Jun-17-25 12:43PM
12:25PM
Jun-16-25 04:30PM
11:00AM
Apr-30-25 06:01AM
Mar-22-25 11:00AM
Mar-21-25 06:35AM
Mar-17-25 07:28AM
Jul-23-24 04:02PM
Nov-15-23 04:31PM
Jul-31-23 08:15AM
Apr-03-23 07:25AM
Feb-21-23 06:36AM
Nov-21-22 06:49AM
07:55AM Loading…
Nov-15-22 07:55AM
Oct-25-22 06:55AM
Sep-14-22 06:55AM
Sep-12-22 09:15AM
Jun-20-22 05:27AM
May-24-22 05:46AM
May-18-22 08:05AM
06:14AM
May-16-22 08:56AM
Apr-14-22 10:03AM
Apr-07-22 06:09AM
Mar-01-22 08:30AM
Feb-17-22 11:40AM
Feb-16-22 08:42PM
Dec-13-21 08:35AM
Nov-22-21 08:15AM
08:00AM
Nov-02-21 04:00AM
Oct-19-21 11:44AM
Sep-10-21 06:18AM
02:42AM
Sep-02-21 08:00AM
Aug-20-21 08:00AM
Aug-05-21 08:00AM
Jul-20-21 04:05PM
Jul-16-21 11:43AM
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.